Family Mechanisms of Structural Ecosystems Therapy for HIV-seropositive Women in Drug Recovery

Overview

Journal Health Psychol

Specialty Public Health

Date 2012 Jun 20

PMID 22708519

Citations 7

Authors

Victoria B Mitrani

Brian E McCabe

Myron J Burns

Daniel J Feaster

Affiliations

Soon will be listed here.

Abstract

Objective: Examined the effects of Structural Ecosystems Therapy (SET), a family intervention for women living with HIV or AIDS, compared to a psycho-educational health group (HG) intervention, and reciprocal relationships between women and family members.

Method: Women (n = 126) and their family members (n = 269) were randomized to one of two conditions and assessed every 4 months for 12 months. Family functioning, drug use, and psychological distress was reported by multiple family members.

Results: Multilevel growth curve modeling showed a different family functioning trajectory between SET and HG, B = -0.05, SE = 0.02, p < .01. There was no intervention effect on the trajectory of family-level drug abstinence or psychological distress, but there was a significant difference in the trajectory of psychological distress after controlling for change in family functioning, B = -0.28, SE = 0.13, p < .05. There was an indirect effect from treatment through change in family functioning to change in psychological distress, B = 0.29, SE = 0.12, p < .05. With respect to reciprocal effects, family drug abstinence significantly predicted women's abstinence 4 months later, B = 0.22, SE = 0.06, p < .001.

Conclusion: Findings demonstrated the interdependence of family members and the impact of family in relapse prevention and partially supported SET's potential for maintaining family functioning and well-being for women living with HIV or AIDS in drug recovery.

Citing Articles

The Mediating Role of Social Support in the Relationship Between Parenting Styles and Adolescent Drug Abuse Identification.

Liu L, Meng W, Liu B Front Psychol. 2022; 12:802408.

PMID: 35082731 PMC: 8784832. DOI: 10.3389/fpsyg.2021.802408.

Mental Health in Women Living With HIV: The Unique and Unmet Needs.

Waldron E, Burnett-Zeigler I, Wee V, Ng Y, Koenig L, Pederson A J Int Assoc Provid AIDS Care. 2021; 20:2325958220985665.

PMID: 33472517 PMC: 7829520. DOI: 10.1177/2325958220985665.

A Refined Model of Stress-Diathesis Relationships in Mothers With Significant Depressive Symptom Severity.

Matsuda Y, Schwartz T, Chang Y, Beeber L J Am Psychiatr Nurses Assoc. 2019; 27(3):240-250.

PMID: 31578899 PMC: 7441645. DOI: 10.1177/1078390319877228.

Mothers in Substance Abuse Recovery: Perspectives on Motivators, Challenges and Family Involvement.

Villegas N, Chodhury S, Mitrani V, Guerra J Int J High Risk Behav Addict. 2019; 6(1).

PMID: 30873391 PMC: 6412135. DOI: 10.5812/ijhrba.32558.

Strategies for improving the lives of US women aged 40 and above living with HIV/AIDS: an evidence map.

Adam G, Di M, Cu-Uvin S, Halladay C, Smith B, Iyer S Syst Rev. 2018; 7(1):25.

PMID: 29391059 PMC: 5796491. DOI: 10.1186/s13643-018-0684-y.

References

Sherer R . Adherence and antiretroviral therapy in injection drug users. JAMA. 1998; 280(6):567-8. DOI: 10.1001/jama.280.6.567. View

Feaster D, Brincks A, Mitrani V, Prado G, Schwartz S, Szapocznik J . The efficacy of Structural Ecosystems Therapy for HIV medication adherence with African American women. J Fam Psychol. 2010; 24(1):51-9. PMC: 2836493. DOI: 10.1037/a0017954. View

Cohen S, Kamarck T, Mermelstein R . A global measure of perceived stress. J Health Soc Behav. 1983; 24(4):385-96. View

Feaster D, Mitrani V, Burns M, McCabe B, Brincks A, Rodriguez A . A randomized controlled trial of Structural Ecosystems Therapy for HIV medication adherence and substance abuse relapse prevention. Drug Alcohol Depend. 2010; 111(3):227-34. PMC: 2950218. DOI: 10.1016/j.drugalcdep.2010.04.017. View

Szapocznik J, Feaster D, Mitrani V, Prado G, Smith L, Robinson-Batista C . Structural ecosystems therapy for HIV-seropositive African American women: effects on psychological distress, family hassles, and family support. J Consult Clin Psychol. 2004; 72(2):288-303. PMC: 1480817. DOI: 10.1037/0022-006X.72.2.288. View

Ndlovu U, Ion A, Carvalhal A . "My children and my home": the most recent and challenging stressors of HIV-positive women. Arch Womens Ment Health. 2010; 13(3):215-22. DOI: 10.1007/s00737-010-0148-4. View

Garcia P, Cote J . Factors affecting adherence to antiretroviral therapy in people living with HIV/AIDS. J Assoc Nurses AIDS Care. 2003; 14(4):37-45. DOI: 10.1177/1055329003252424. View

Murphy D, Greenwell L, Hoffman D . Factors associated with antiretroviral adherence among HIV-infected women with children. Women Health. 2002; 36(1):97-111. DOI: 10.1300/J013v36n01_07. View

Cole S, Hernan M, Anastos K, Jamieson B, Robins J . Determining the effect of highly active antiretroviral therapy on changes in human immunodeficiency virus type 1 RNA viral load using a marginal structural left-censored mean model. Am J Epidemiol. 2007; 166(2):219-27. DOI: 10.1093/aje/kwm047. View

10.

Lucas G, Cheever L, Chaisson R, Moore R . Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection. J Acquir Immune Defic Syndr. 2001; 27(3):251-9. DOI: 10.1097/00126334-200107010-00006. View

11.

Lester P, Stein J, Bursch B, Rice E, Green S, Penniman T . Family-based processes associated with adolescent distress, substance use and risky sexual behavior in families affected by maternal HIV. J Clin Child Adolesc Psychol. 2010; 39(3):328-40. PMC: 4186713. DOI: 10.1080/15374411003691677. View

12.

Merenstein D, Schneider M, Cox C, Schwartz R, Weber K, Robison E . Association of child care burden and household composition with adherence to highly active antiretroviral therapy in the Women's Interagency HIV Study. AIDS Patient Care STDS. 2009; 23(4):289-96. PMC: 2674283. DOI: 10.1089/apc.2008.0161. View

13.

Barroso J, Sandelowski M . Substance abuse in HIV-positive women. J Assoc Nurses AIDS Care. 2004; 15(5):48-59. DOI: 10.1177/1055329004269086. View

14.

Remien R, Exner T, Kertzner R, Ehrhardt A, Rotheram-Borus M, Johnson M . Depressive symptomatology among HIV-positive women in the era of HAART: a stress and coping model. Am J Community Psychol. 2006; 38(3-4):275-85. DOI: 10.1007/s10464-006-9083-y. View

15.

Bing E, Burnam M, Longshore D, Fleishman J, Sherbourne C, London A . Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry. 2001; 58(8):721-8. DOI: 10.1001/archpsyc.58.8.721. View

16.

DiMatteo M . Social support and patient adherence to medical treatment: a meta-analysis. Health Psychol. 2004; 23(2):207-18. DOI: 10.1037/0278-6133.23.2.207. View

17.

Mitrani V, Weiss-Laxer N, Ow C, Ross-Russell S, Burns M, Feaster D . Examining family networks of HIV+ women in drug recovery: challenges and opportunities. Fam Syst Health. 2009; 27(3):267-283. PMC: 2845531. DOI: 10.1037/a0017116. View

18.

Feaster D, Burns M, Brincks A, Prado G, Mitrani V, Mauer M . Structural Ecosystems Therapy for HIV+ African-American women and drug abuse relapse. Fam Process. 2010; 49(2):204-19. PMC: 4048062. DOI: 10.1111/j.1545-5300.2010.01318.x. View

19.

Ickovics J, Hamburger M, Vlahov D, Schoenbaum E, Schuman P, Boland R . Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. JAMA. 2001; 285(11):1466-74. DOI: 10.1001/jama.285.11.1466. View

20.

Krause M, Serlin R, Ward S, Zisk Rony R, Ezenwa M, Naab F . Testing mediation in nursing research: beyond Baron and Kenny. Nurs Res. 2010; 59(4):288-94. PMC: 2920601. DOI: 10.1097/NNR.0b013e3181dd26b3. View